Production (Stage)
Raia Drogasil S.A.
RADLY
$2.47
-$0.17-6.44%
OTC PK
| 03/31/2025 | 12/31/2024 | 09/30/2024 | 06/30/2024 | 03/31/2024 | |
|---|---|---|---|---|---|
| Revenue | -0.31% | 6.03% | 12.31% | 18.33% | 20.59% |
| Total Other Revenue | -- | -- | -- | -- | -- |
| Total Revenue | -0.31% | 6.03% | 12.31% | 18.33% | 20.59% |
| Cost of Revenue | 0.28% | 6.55% | 12.68% | 18.63% | 21.17% |
| Gross Profit | -1.68% | 4.84% | 11.44% | 17.61% | 19.24% |
| SG&A Expenses | -1.24% | 3.92% | 11.57% | 18.90% | 20.93% |
| Depreciation & Amortization | -- | -- | -- | -- | -- |
| Other Operating Expenses | 124.46% | 149.67% | -6.79% | -258.40% | -65.71% |
| Total Operating Expenses | 0.35% | 6.50% | 12.41% | 18.44% | 20.99% |
| Operating Income | -10.03% | -0.85% | 10.84% | 16.66% | 14.95% |
| Income Before Tax | -7.98% | 7.69% | 14.39% | 11.68% | 6.50% |
| Income Tax Expenses | -31.39% | 55.51% | 136.06% | 66.33% | 14.34% |
| Earnings from Continuing Operations | -3.42% | 1.95% | 1.08% | 4.50% | 5.10% |
| Earnings from Discontinued Operations | -- | -- | -- | -- | -- |
| Extraordinary Item & Accounting Change | -- | -- | -- | -- | -- |
| Minority Interest in Earnings | 79.96% | 65.82% | -65.26% | -72.45% | -54.84% |
| Net Income | -1.09% | 4.03% | 0.04% | 3.34% | 4.08% |
| EBIT | -10.03% | -0.85% | 10.84% | 16.66% | 14.95% |
| EBITDA | -8.74% | -0.56% | 9.38% | 15.19% | 14.37% |
| EPS Basic | -11.78% | -6.00% | -11.02% | -8.89% | 5.86% |
| Normalized Basic EPS | -22.30% | -9.66% | 1.73% | 3.39% | 9.70% |
| EPS Diluted | -11.81% | -6.09% | -11.07% | -8.68% | 6.41% |
| Normalized Diluted EPS | -22.35% | -9.80% | 1.62% | 3.52% | 10.09% |
| Average Basic Shares Outstanding | 16.13% | 15.06% | 16.06% | 16.21% | -1.85% |
| Average Diluted Shares Outstanding | 16.07% | 14.87% | 15.83% | 15.71% | -2.36% |
| Dividend Per Share | -57.85% | -63.79% | 213.81% | 1.66% | 82.06% |
| Payout Ratio | -0.08% | -0.12% | 0.05% | 0.02% | 0.44% |